Global Anti-infectious Disease Drugs Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Anti-infectious Disease Drugs Industry Forecast” looks at past sales and reviews total world Anti-infectious Disease Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-infectious Disease Drugs sales for 2023 through 2029. With Anti-infectious Disease Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-infectious Disease Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anti-infectious Disease Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-infectious Disease Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Anti-infectious Disease Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-infectious Disease Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-infectious Disease Drugs.
The global Anti-infectious Disease Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Anti-infectious Disease Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Anti-infectious Disease Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Anti-infectious Disease Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Anti-infectious Disease Drugs players cover Aridis Pharmaceuticals, AiCuris, Sandoz, Anhui Jingfang Medical Industry Co.,Ltd, Beijing Double-Crane Pharmaceutical Co., Ltd., Abbott, Spero Therapeutics, Adlyfe, Inc. and Advanced Life Sciences Holdings, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-infectious Disease Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Anti-infectious Disease Drugs market?
What factors are driving Anti-infectious Disease Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-infectious Disease Drugs market opportunities vary by end market size?
How does Anti-infectious Disease Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Anti-infectious Disease Drugs Industry Forecast” looks at past sales and reviews total world Anti-infectious Disease Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-infectious Disease Drugs sales for 2023 through 2029. With Anti-infectious Disease Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-infectious Disease Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anti-infectious Disease Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-infectious Disease Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Anti-infectious Disease Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-infectious Disease Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-infectious Disease Drugs.
The global Anti-infectious Disease Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Anti-infectious Disease Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Anti-infectious Disease Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Anti-infectious Disease Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Anti-infectious Disease Drugs players cover Aridis Pharmaceuticals, AiCuris, Sandoz, Anhui Jingfang Medical Industry Co.,Ltd, Beijing Double-Crane Pharmaceutical Co., Ltd., Abbott, Spero Therapeutics, Adlyfe, Inc. and Advanced Life Sciences Holdings, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-infectious Disease Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Antibacterial Drugs
- Antifungal Drugs
- Antiviral Drugs
- Antiparasitic Drugs
- Hospital
- Institute of Medicine
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Aridis Pharmaceuticals
- AiCuris
- Sandoz
- Anhui Jingfang Medical Industry Co.,Ltd
- Beijing Double-Crane Pharmaceutical Co., Ltd.
- Abbott
- Spero Therapeutics
- Adlyfe, Inc.
- Advanced Life Sciences Holdings, Inc.
- Affinium Pharmaceuticals
- APP Pharmaceuticals
- Aquapharm Biodiscovery
- Basilea Pharmaceutica AG
- Biophage Pharma, Inc.
What is the 10-year outlook for the global Anti-infectious Disease Drugs market?
What factors are driving Anti-infectious Disease Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-infectious Disease Drugs market opportunities vary by end market size?
How does Anti-infectious Disease Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-infectious Disease Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Anti-infectious Disease Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Anti-infectious Disease Drugs by Country/Region, 2018, 2022 & 2029
2.2 Anti-infectious Disease Drugs Segment by Type
2.2.1 Antibacterial Drugs
2.2.2 Antifungal Drugs
2.2.3 Antiviral Drugs
2.2.4 Antiparasitic Drugs
2.3 Anti-infectious Disease Drugs Sales by Type
2.3.1 Global Anti-infectious Disease Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Anti-infectious Disease Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Anti-infectious Disease Drugs Sale Price by Type (2018-2023)
2.4 Anti-infectious Disease Drugs Segment by Application
2.4.1 Hospital
2.4.2 Institute of Medicine
2.4.3 Clinic
2.4.4 Others
2.5 Anti-infectious Disease Drugs Sales by Application
2.5.1 Global Anti-infectious Disease Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Anti-infectious Disease Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Anti-infectious Disease Drugs Sale Price by Application (2018-2023)
3 GLOBAL ANTI-INFECTIOUS DISEASE DRUGS BY COMPANY
3.1 Global Anti-infectious Disease Drugs Breakdown Data by Company
3.1.1 Global Anti-infectious Disease Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Anti-infectious Disease Drugs Sales Market Share by Company (2018-2023)
3.2 Global Anti-infectious Disease Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Anti-infectious Disease Drugs Revenue by Company (2018-2023)
3.2.2 Global Anti-infectious Disease Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Anti-infectious Disease Drugs Sale Price by Company
3.4 Key Manufacturers Anti-infectious Disease Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-infectious Disease Drugs Product Location Distribution
3.4.2 Players Anti-infectious Disease Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ANTI-INFECTIOUS DISEASE DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Anti-infectious Disease Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Anti-infectious Disease Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Anti-infectious Disease Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Anti-infectious Disease Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Anti-infectious Disease Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Anti-infectious Disease Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Anti-infectious Disease Drugs Sales Growth
4.4 APAC Anti-infectious Disease Drugs Sales Growth
4.5 Europe Anti-infectious Disease Drugs Sales Growth
4.6 Middle East & Africa Anti-infectious Disease Drugs Sales Growth
5 AMERICAS
5.1 Americas Anti-infectious Disease Drugs Sales by Country
5.1.1 Americas Anti-infectious Disease Drugs Sales by Country (2018-2023)
5.1.2 Americas Anti-infectious Disease Drugs Revenue by Country (2018-2023)
5.2 Americas Anti-infectious Disease Drugs Sales by Type
5.3 Americas Anti-infectious Disease Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-infectious Disease Drugs Sales by Region
6.1.1 APAC Anti-infectious Disease Drugs Sales by Region (2018-2023)
6.1.2 APAC Anti-infectious Disease Drugs Revenue by Region (2018-2023)
6.2 APAC Anti-infectious Disease Drugs Sales by Type
6.3 APAC Anti-infectious Disease Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-infectious Disease Drugs by Country
7.1.1 Europe Anti-infectious Disease Drugs Sales by Country (2018-2023)
7.1.2 Europe Anti-infectious Disease Drugs Revenue by Country (2018-2023)
7.2 Europe Anti-infectious Disease Drugs Sales by Type
7.3 Europe Anti-infectious Disease Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-infectious Disease Drugs by Country
8.1.1 Middle East & Africa Anti-infectious Disease Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Anti-infectious Disease Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Anti-infectious Disease Drugs Sales by Type
8.3 Middle East & Africa Anti-infectious Disease Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-infectious Disease Drugs
10.3 Manufacturing Process Analysis of Anti-infectious Disease Drugs
10.4 Industry Chain Structure of Anti-infectious Disease Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-infectious Disease Drugs Distributors
11.3 Anti-infectious Disease Drugs Customer
12 WORLD FORECAST REVIEW FOR ANTI-INFECTIOUS DISEASE DRUGS BY GEOGRAPHIC REGION
12.1 Global Anti-infectious Disease Drugs Market Size Forecast by Region
12.1.1 Global Anti-infectious Disease Drugs Forecast by Region (2024-2029)
12.1.2 Global Anti-infectious Disease Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-infectious Disease Drugs Forecast by Type
12.7 Global Anti-infectious Disease Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Aridis Pharmaceuticals
13.1.1 Aridis Pharmaceuticals Company Information
13.1.2 Aridis Pharmaceuticals Anti-infectious Disease Drugs Product Portfolios and Specifications
13.1.3 Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Aridis Pharmaceuticals Main Business Overview
13.1.5 Aridis Pharmaceuticals Latest Developments
13.2 AiCuris
13.2.1 AiCuris Company Information
13.2.2 AiCuris Anti-infectious Disease Drugs Product Portfolios and Specifications
13.2.3 AiCuris Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AiCuris Main Business Overview
13.2.5 AiCuris Latest Developments
13.3 Sandoz
13.3.1 Sandoz Company Information
13.3.2 Sandoz Anti-infectious Disease Drugs Product Portfolios and Specifications
13.3.3 Sandoz Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sandoz Main Business Overview
13.3.5 Sandoz Latest Developments
13.4 Anhui Jingfang Medical Industry Co.,Ltd
13.4.1 Anhui Jingfang Medical Industry Co.,Ltd Company Information
13.4.2 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product Portfolios and Specifications
13.4.3 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Anhui Jingfang Medical Industry Co.,Ltd Main Business Overview
13.4.5 Anhui Jingfang Medical Industry Co.,Ltd Latest Developments
13.5 Beijing Double-Crane Pharmaceutical Co., Ltd.
13.5.1 Beijing Double-Crane Pharmaceutical Co., Ltd. Company Information
13.5.2 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product Portfolios and Specifications
13.5.3 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Beijing Double-Crane Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Beijing Double-Crane Pharmaceutical Co., Ltd. Latest Developments
13.6 Abbott
13.6.1 Abbott Company Information
13.6.2 Abbott Anti-infectious Disease Drugs Product Portfolios and Specifications
13.6.3 Abbott Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Abbott Main Business Overview
13.6.5 Abbott Latest Developments
13.7 Spero Therapeutics
13.7.1 Spero Therapeutics Company Information
13.7.2 Spero Therapeutics Anti-infectious Disease Drugs Product Portfolios and Specifications
13.7.3 Spero Therapeutics Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Spero Therapeutics Main Business Overview
13.7.5 Spero Therapeutics Latest Developments
13.8 Adlyfe, Inc.
13.8.1 Adlyfe, Inc. Company Information
13.8.2 Adlyfe, Inc. Anti-infectious Disease Drugs Product Portfolios and Specifications
13.8.3 Adlyfe, Inc. Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Adlyfe, Inc. Main Business Overview
13.8.5 Adlyfe, Inc. Latest Developments
13.9 Advanced Life Sciences Holdings, Inc.
13.9.1 Advanced Life Sciences Holdings, Inc. Company Information
13.9.2 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product Portfolios and Specifications
13.9.3 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Advanced Life Sciences Holdings, Inc. Main Business Overview
13.9.5 Advanced Life Sciences Holdings, Inc. Latest Developments
13.10 Affinium Pharmaceuticals
13.10.1 Affinium Pharmaceuticals Company Information
13.10.2 Affinium Pharmaceuticals Anti-infectious Disease Drugs Product Portfolios and Specifications
13.10.3 Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Affinium Pharmaceuticals Main Business Overview
13.10.5 Affinium Pharmaceuticals Latest Developments
13.11 APP Pharmaceuticals
13.11.1 APP Pharmaceuticals Company Information
13.11.2 APP Pharmaceuticals Anti-infectious Disease Drugs Product Portfolios and Specifications
13.11.3 APP Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 APP Pharmaceuticals Main Business Overview
13.11.5 APP Pharmaceuticals Latest Developments
13.12 Aquapharm Biodiscovery
13.12.1 Aquapharm Biodiscovery Company Information
13.12.2 Aquapharm Biodiscovery Anti-infectious Disease Drugs Product Portfolios and Specifications
13.12.3 Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Aquapharm Biodiscovery Main Business Overview
13.12.5 Aquapharm Biodiscovery Latest Developments
13.13 Basilea Pharmaceutica AG
13.13.1 Basilea Pharmaceutica AG Company Information
13.13.2 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product Portfolios and Specifications
13.13.3 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Basilea Pharmaceutica AG Main Business Overview
13.13.5 Basilea Pharmaceutica AG Latest Developments
13.14 Biophage Pharma, Inc.
13.14.1 Biophage Pharma, Inc. Company Information
13.14.2 Biophage Pharma, Inc. Anti-infectious Disease Drugs Product Portfolios and Specifications
13.14.3 Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Biophage Pharma, Inc. Main Business Overview
13.14.5 Biophage Pharma, Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-infectious Disease Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Anti-infectious Disease Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Anti-infectious Disease Drugs by Country/Region, 2018, 2022 & 2029
2.2 Anti-infectious Disease Drugs Segment by Type
2.2.1 Antibacterial Drugs
2.2.2 Antifungal Drugs
2.2.3 Antiviral Drugs
2.2.4 Antiparasitic Drugs
2.3 Anti-infectious Disease Drugs Sales by Type
2.3.1 Global Anti-infectious Disease Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Anti-infectious Disease Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Anti-infectious Disease Drugs Sale Price by Type (2018-2023)
2.4 Anti-infectious Disease Drugs Segment by Application
2.4.1 Hospital
2.4.2 Institute of Medicine
2.4.3 Clinic
2.4.4 Others
2.5 Anti-infectious Disease Drugs Sales by Application
2.5.1 Global Anti-infectious Disease Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Anti-infectious Disease Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Anti-infectious Disease Drugs Sale Price by Application (2018-2023)
3 GLOBAL ANTI-INFECTIOUS DISEASE DRUGS BY COMPANY
3.1 Global Anti-infectious Disease Drugs Breakdown Data by Company
3.1.1 Global Anti-infectious Disease Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Anti-infectious Disease Drugs Sales Market Share by Company (2018-2023)
3.2 Global Anti-infectious Disease Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Anti-infectious Disease Drugs Revenue by Company (2018-2023)
3.2.2 Global Anti-infectious Disease Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Anti-infectious Disease Drugs Sale Price by Company
3.4 Key Manufacturers Anti-infectious Disease Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-infectious Disease Drugs Product Location Distribution
3.4.2 Players Anti-infectious Disease Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ANTI-INFECTIOUS DISEASE DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Anti-infectious Disease Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Anti-infectious Disease Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Anti-infectious Disease Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Anti-infectious Disease Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Anti-infectious Disease Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Anti-infectious Disease Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Anti-infectious Disease Drugs Sales Growth
4.4 APAC Anti-infectious Disease Drugs Sales Growth
4.5 Europe Anti-infectious Disease Drugs Sales Growth
4.6 Middle East & Africa Anti-infectious Disease Drugs Sales Growth
5 AMERICAS
5.1 Americas Anti-infectious Disease Drugs Sales by Country
5.1.1 Americas Anti-infectious Disease Drugs Sales by Country (2018-2023)
5.1.2 Americas Anti-infectious Disease Drugs Revenue by Country (2018-2023)
5.2 Americas Anti-infectious Disease Drugs Sales by Type
5.3 Americas Anti-infectious Disease Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-infectious Disease Drugs Sales by Region
6.1.1 APAC Anti-infectious Disease Drugs Sales by Region (2018-2023)
6.1.2 APAC Anti-infectious Disease Drugs Revenue by Region (2018-2023)
6.2 APAC Anti-infectious Disease Drugs Sales by Type
6.3 APAC Anti-infectious Disease Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-infectious Disease Drugs by Country
7.1.1 Europe Anti-infectious Disease Drugs Sales by Country (2018-2023)
7.1.2 Europe Anti-infectious Disease Drugs Revenue by Country (2018-2023)
7.2 Europe Anti-infectious Disease Drugs Sales by Type
7.3 Europe Anti-infectious Disease Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-infectious Disease Drugs by Country
8.1.1 Middle East & Africa Anti-infectious Disease Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Anti-infectious Disease Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Anti-infectious Disease Drugs Sales by Type
8.3 Middle East & Africa Anti-infectious Disease Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-infectious Disease Drugs
10.3 Manufacturing Process Analysis of Anti-infectious Disease Drugs
10.4 Industry Chain Structure of Anti-infectious Disease Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-infectious Disease Drugs Distributors
11.3 Anti-infectious Disease Drugs Customer
12 WORLD FORECAST REVIEW FOR ANTI-INFECTIOUS DISEASE DRUGS BY GEOGRAPHIC REGION
12.1 Global Anti-infectious Disease Drugs Market Size Forecast by Region
12.1.1 Global Anti-infectious Disease Drugs Forecast by Region (2024-2029)
12.1.2 Global Anti-infectious Disease Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-infectious Disease Drugs Forecast by Type
12.7 Global Anti-infectious Disease Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Aridis Pharmaceuticals
13.1.1 Aridis Pharmaceuticals Company Information
13.1.2 Aridis Pharmaceuticals Anti-infectious Disease Drugs Product Portfolios and Specifications
13.1.3 Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Aridis Pharmaceuticals Main Business Overview
13.1.5 Aridis Pharmaceuticals Latest Developments
13.2 AiCuris
13.2.1 AiCuris Company Information
13.2.2 AiCuris Anti-infectious Disease Drugs Product Portfolios and Specifications
13.2.3 AiCuris Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AiCuris Main Business Overview
13.2.5 AiCuris Latest Developments
13.3 Sandoz
13.3.1 Sandoz Company Information
13.3.2 Sandoz Anti-infectious Disease Drugs Product Portfolios and Specifications
13.3.3 Sandoz Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sandoz Main Business Overview
13.3.5 Sandoz Latest Developments
13.4 Anhui Jingfang Medical Industry Co.,Ltd
13.4.1 Anhui Jingfang Medical Industry Co.,Ltd Company Information
13.4.2 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product Portfolios and Specifications
13.4.3 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Anhui Jingfang Medical Industry Co.,Ltd Main Business Overview
13.4.5 Anhui Jingfang Medical Industry Co.,Ltd Latest Developments
13.5 Beijing Double-Crane Pharmaceutical Co., Ltd.
13.5.1 Beijing Double-Crane Pharmaceutical Co., Ltd. Company Information
13.5.2 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product Portfolios and Specifications
13.5.3 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Beijing Double-Crane Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Beijing Double-Crane Pharmaceutical Co., Ltd. Latest Developments
13.6 Abbott
13.6.1 Abbott Company Information
13.6.2 Abbott Anti-infectious Disease Drugs Product Portfolios and Specifications
13.6.3 Abbott Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Abbott Main Business Overview
13.6.5 Abbott Latest Developments
13.7 Spero Therapeutics
13.7.1 Spero Therapeutics Company Information
13.7.2 Spero Therapeutics Anti-infectious Disease Drugs Product Portfolios and Specifications
13.7.3 Spero Therapeutics Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Spero Therapeutics Main Business Overview
13.7.5 Spero Therapeutics Latest Developments
13.8 Adlyfe, Inc.
13.8.1 Adlyfe, Inc. Company Information
13.8.2 Adlyfe, Inc. Anti-infectious Disease Drugs Product Portfolios and Specifications
13.8.3 Adlyfe, Inc. Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Adlyfe, Inc. Main Business Overview
13.8.5 Adlyfe, Inc. Latest Developments
13.9 Advanced Life Sciences Holdings, Inc.
13.9.1 Advanced Life Sciences Holdings, Inc. Company Information
13.9.2 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product Portfolios and Specifications
13.9.3 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Advanced Life Sciences Holdings, Inc. Main Business Overview
13.9.5 Advanced Life Sciences Holdings, Inc. Latest Developments
13.10 Affinium Pharmaceuticals
13.10.1 Affinium Pharmaceuticals Company Information
13.10.2 Affinium Pharmaceuticals Anti-infectious Disease Drugs Product Portfolios and Specifications
13.10.3 Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Affinium Pharmaceuticals Main Business Overview
13.10.5 Affinium Pharmaceuticals Latest Developments
13.11 APP Pharmaceuticals
13.11.1 APP Pharmaceuticals Company Information
13.11.2 APP Pharmaceuticals Anti-infectious Disease Drugs Product Portfolios and Specifications
13.11.3 APP Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 APP Pharmaceuticals Main Business Overview
13.11.5 APP Pharmaceuticals Latest Developments
13.12 Aquapharm Biodiscovery
13.12.1 Aquapharm Biodiscovery Company Information
13.12.2 Aquapharm Biodiscovery Anti-infectious Disease Drugs Product Portfolios and Specifications
13.12.3 Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Aquapharm Biodiscovery Main Business Overview
13.12.5 Aquapharm Biodiscovery Latest Developments
13.13 Basilea Pharmaceutica AG
13.13.1 Basilea Pharmaceutica AG Company Information
13.13.2 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product Portfolios and Specifications
13.13.3 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Basilea Pharmaceutica AG Main Business Overview
13.13.5 Basilea Pharmaceutica AG Latest Developments
13.14 Biophage Pharma, Inc.
13.14.1 Biophage Pharma, Inc. Company Information
13.14.2 Biophage Pharma, Inc. Anti-infectious Disease Drugs Product Portfolios and Specifications
13.14.3 Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Biophage Pharma, Inc. Main Business Overview
13.14.5 Biophage Pharma, Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Anti-infectious Disease Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Anti-infectious Disease Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Antibacterial Drugs
Table 4. Major Players of Antifungal Drugs
Table 5. Major Players of Antiviral Drugs
Table 6. Major Players of Antiparasitic Drugs
Table 7. Global Anti-infectious Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 8. Global Anti-infectious Disease Drugs Sales Market Share by Type (2018-2023)
Table 9. Global Anti-infectious Disease Drugs Revenue by Type (2018-2023) & ($ million)
Table 10. Global Anti-infectious Disease Drugs Revenue Market Share by Type (2018-2023)
Table 11. Global Anti-infectious Disease Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Anti-infectious Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 13. Global Anti-infectious Disease Drugs Sales Market Share by Application (2018-2023)
Table 14. Global Anti-infectious Disease Drugs Revenue by Application (2018-2023)
Table 15. Global Anti-infectious Disease Drugs Revenue Market Share by Application (2018-2023)
Table 16. Global Anti-infectious Disease Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Anti-infectious Disease Drugs Sales by Company (2018-2023) & (K Units)
Table 18. Global Anti-infectious Disease Drugs Sales Market Share by Company (2018-2023)
Table 19. Global Anti-infectious Disease Drugs Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Anti-infectious Disease Drugs Revenue Market Share by Company (2018-2023)
Table 21. Global Anti-infectious Disease Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Anti-infectious Disease Drugs Producing Area Distribution and Sales Area
Table 23. Players Anti-infectious Disease Drugs Products Offered
Table 24. Anti-infectious Disease Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Anti-infectious Disease Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Anti-infectious Disease Drugs Sales Market Share Geographic Region (2018-2023)
Table 29. Global Anti-infectious Disease Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Anti-infectious Disease Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Anti-infectious Disease Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Anti-infectious Disease Drugs Sales Market Share by Country/Region (2018-2023)
Table 33. Global Anti-infectious Disease Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Anti-infectious Disease Drugs Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Anti-infectious Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 36. Americas Anti-infectious Disease Drugs Sales Market Share by Country (2018-2023)
Table 37. Americas Anti-infectious Disease Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Anti-infectious Disease Drugs Revenue Market Share by Country (2018-2023)
Table 39. Americas Anti-infectious Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 40. Americas Anti-infectious Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 41. APAC Anti-infectious Disease Drugs Sales by Region (2018-2023) & (K Units)
Table 42. APAC Anti-infectious Disease Drugs Sales Market Share by Region (2018-2023)
Table 43. APAC Anti-infectious Disease Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Anti-infectious Disease Drugs Revenue Market Share by Region (2018-2023)
Table 45. APAC Anti-infectious Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 46. APAC Anti-infectious Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 47. Europe Anti-infectious Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 48. Europe Anti-infectious Disease Drugs Sales Market Share by Country (2018-2023)
Table 49. Europe Anti-infectious Disease Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Anti-infectious Disease Drugs Revenue Market Share by Country (2018-2023)
Table 51. Europe Anti-infectious Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 52. Europe Anti-infectious Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Anti-infectious Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Anti-infectious Disease Drugs Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Anti-infectious Disease Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Anti-infectious Disease Drugs Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Anti-infectious Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Anti-infectious Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Anti-infectious Disease Drugs
Table 60. Key Market Challenges & Risks of Anti-infectious Disease Drugs
Table 61. Key Industry Trends of Anti-infectious Disease Drugs
Table 62. Anti-infectious Disease Drugs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Anti-infectious Disease Drugs Distributors List
Table 65. Anti-infectious Disease Drugs Customer List
Table 66. Global Anti-infectious Disease Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Anti-infectious Disease Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Anti-infectious Disease Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Anti-infectious Disease Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Anti-infectious Disease Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Anti-infectious Disease Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Anti-infectious Disease Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Anti-infectious Disease Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Anti-infectious Disease Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Anti-infectious Disease Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Anti-infectious Disease Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Anti-infectious Disease Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Anti-infectious Disease Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Anti-infectious Disease Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Aridis Pharmaceuticals Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Aridis Pharmaceuticals Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 82. Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Aridis Pharmaceuticals Main Business
Table 84. Aridis Pharmaceuticals Latest Developments
Table 85. AiCuris Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. AiCuris Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 87. AiCuris Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. AiCuris Main Business
Table 89. AiCuris Latest Developments
Table 90. Sandoz Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Sandoz Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 92. Sandoz Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Sandoz Main Business
Table 94. Sandoz Latest Developments
Table 95. Anhui Jingfang Medical Industry Co.,Ltd Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 97. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Anhui Jingfang Medical Industry Co.,Ltd Main Business
Table 99. Anhui Jingfang Medical Industry Co.,Ltd Latest Developments
Table 100. Beijing Double-Crane Pharmaceutical Co., Ltd. Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 102. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Beijing Double-Crane Pharmaceutical Co., Ltd. Main Business
Table 104. Beijing Double-Crane Pharmaceutical Co., Ltd. Latest Developments
Table 105. Abbott Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Abbott Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 107. Abbott Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Abbott Main Business
Table 109. Abbott Latest Developments
Table 110. Spero Therapeutics Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Spero Therapeutics Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 112. Spero Therapeutics Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Spero Therapeutics Main Business
Table 114. Spero Therapeutics Latest Developments
Table 115. Adlyfe, Inc. Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Adlyfe, Inc. Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 117. Adlyfe, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Adlyfe, Inc. Main Business
Table 119. Adlyfe, Inc. Latest Developments
Table 120. Advanced Life Sciences Holdings, Inc. Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 122. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Advanced Life Sciences Holdings, Inc. Main Business
Table 124. Advanced Life Sciences Holdings, Inc. Latest Developments
Table 125. Affinium Pharmaceuticals Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Affinium Pharmaceuticals Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 127. Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Affinium Pharmaceuticals Main Business
Table 129. Affinium Pharmaceuticals Latest Developments
Table 130. APP Pharmaceuticals Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. APP Pharmaceuticals Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 132. APP Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. APP Pharmaceuticals Main Business
Table 134. APP Pharmaceuticals Latest Developments
Table 135. Aquapharm Biodiscovery Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Aquapharm Biodiscovery Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 137. Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Aquapharm Biodiscovery Main Business
Table 139. Aquapharm Biodiscovery Latest Developments
Table 140. Basilea Pharmaceutica AG Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 142. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Basilea Pharmaceutica AG Main Business
Table 144. Basilea Pharmaceutica AG Latest Developments
Table 145. Biophage Pharma, Inc. Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Biophage Pharma, Inc. Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 147. Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Biophage Pharma, Inc. Main Business
Table 149. Biophage Pharma, Inc. Latest Developments
Table 1. Anti-infectious Disease Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Anti-infectious Disease Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Antibacterial Drugs
Table 4. Major Players of Antifungal Drugs
Table 5. Major Players of Antiviral Drugs
Table 6. Major Players of Antiparasitic Drugs
Table 7. Global Anti-infectious Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 8. Global Anti-infectious Disease Drugs Sales Market Share by Type (2018-2023)
Table 9. Global Anti-infectious Disease Drugs Revenue by Type (2018-2023) & ($ million)
Table 10. Global Anti-infectious Disease Drugs Revenue Market Share by Type (2018-2023)
Table 11. Global Anti-infectious Disease Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Anti-infectious Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 13. Global Anti-infectious Disease Drugs Sales Market Share by Application (2018-2023)
Table 14. Global Anti-infectious Disease Drugs Revenue by Application (2018-2023)
Table 15. Global Anti-infectious Disease Drugs Revenue Market Share by Application (2018-2023)
Table 16. Global Anti-infectious Disease Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Anti-infectious Disease Drugs Sales by Company (2018-2023) & (K Units)
Table 18. Global Anti-infectious Disease Drugs Sales Market Share by Company (2018-2023)
Table 19. Global Anti-infectious Disease Drugs Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Anti-infectious Disease Drugs Revenue Market Share by Company (2018-2023)
Table 21. Global Anti-infectious Disease Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Anti-infectious Disease Drugs Producing Area Distribution and Sales Area
Table 23. Players Anti-infectious Disease Drugs Products Offered
Table 24. Anti-infectious Disease Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Anti-infectious Disease Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Anti-infectious Disease Drugs Sales Market Share Geographic Region (2018-2023)
Table 29. Global Anti-infectious Disease Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Anti-infectious Disease Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Anti-infectious Disease Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Anti-infectious Disease Drugs Sales Market Share by Country/Region (2018-2023)
Table 33. Global Anti-infectious Disease Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Anti-infectious Disease Drugs Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Anti-infectious Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 36. Americas Anti-infectious Disease Drugs Sales Market Share by Country (2018-2023)
Table 37. Americas Anti-infectious Disease Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Anti-infectious Disease Drugs Revenue Market Share by Country (2018-2023)
Table 39. Americas Anti-infectious Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 40. Americas Anti-infectious Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 41. APAC Anti-infectious Disease Drugs Sales by Region (2018-2023) & (K Units)
Table 42. APAC Anti-infectious Disease Drugs Sales Market Share by Region (2018-2023)
Table 43. APAC Anti-infectious Disease Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Anti-infectious Disease Drugs Revenue Market Share by Region (2018-2023)
Table 45. APAC Anti-infectious Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 46. APAC Anti-infectious Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 47. Europe Anti-infectious Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 48. Europe Anti-infectious Disease Drugs Sales Market Share by Country (2018-2023)
Table 49. Europe Anti-infectious Disease Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Anti-infectious Disease Drugs Revenue Market Share by Country (2018-2023)
Table 51. Europe Anti-infectious Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 52. Europe Anti-infectious Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Anti-infectious Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Anti-infectious Disease Drugs Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Anti-infectious Disease Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Anti-infectious Disease Drugs Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Anti-infectious Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Anti-infectious Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Anti-infectious Disease Drugs
Table 60. Key Market Challenges & Risks of Anti-infectious Disease Drugs
Table 61. Key Industry Trends of Anti-infectious Disease Drugs
Table 62. Anti-infectious Disease Drugs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Anti-infectious Disease Drugs Distributors List
Table 65. Anti-infectious Disease Drugs Customer List
Table 66. Global Anti-infectious Disease Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Anti-infectious Disease Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Anti-infectious Disease Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Anti-infectious Disease Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Anti-infectious Disease Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Anti-infectious Disease Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Anti-infectious Disease Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Anti-infectious Disease Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Anti-infectious Disease Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Anti-infectious Disease Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Anti-infectious Disease Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Anti-infectious Disease Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Anti-infectious Disease Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Anti-infectious Disease Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Aridis Pharmaceuticals Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Aridis Pharmaceuticals Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 82. Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Aridis Pharmaceuticals Main Business
Table 84. Aridis Pharmaceuticals Latest Developments
Table 85. AiCuris Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. AiCuris Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 87. AiCuris Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. AiCuris Main Business
Table 89. AiCuris Latest Developments
Table 90. Sandoz Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Sandoz Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 92. Sandoz Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Sandoz Main Business
Table 94. Sandoz Latest Developments
Table 95. Anhui Jingfang Medical Industry Co.,Ltd Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 97. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Anhui Jingfang Medical Industry Co.,Ltd Main Business
Table 99. Anhui Jingfang Medical Industry Co.,Ltd Latest Developments
Table 100. Beijing Double-Crane Pharmaceutical Co., Ltd. Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 102. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Beijing Double-Crane Pharmaceutical Co., Ltd. Main Business
Table 104. Beijing Double-Crane Pharmaceutical Co., Ltd. Latest Developments
Table 105. Abbott Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Abbott Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 107. Abbott Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Abbott Main Business
Table 109. Abbott Latest Developments
Table 110. Spero Therapeutics Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Spero Therapeutics Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 112. Spero Therapeutics Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Spero Therapeutics Main Business
Table 114. Spero Therapeutics Latest Developments
Table 115. Adlyfe, Inc. Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Adlyfe, Inc. Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 117. Adlyfe, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Adlyfe, Inc. Main Business
Table 119. Adlyfe, Inc. Latest Developments
Table 120. Advanced Life Sciences Holdings, Inc. Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 122. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Advanced Life Sciences Holdings, Inc. Main Business
Table 124. Advanced Life Sciences Holdings, Inc. Latest Developments
Table 125. Affinium Pharmaceuticals Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Affinium Pharmaceuticals Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 127. Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Affinium Pharmaceuticals Main Business
Table 129. Affinium Pharmaceuticals Latest Developments
Table 130. APP Pharmaceuticals Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. APP Pharmaceuticals Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 132. APP Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. APP Pharmaceuticals Main Business
Table 134. APP Pharmaceuticals Latest Developments
Table 135. Aquapharm Biodiscovery Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Aquapharm Biodiscovery Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 137. Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Aquapharm Biodiscovery Main Business
Table 139. Aquapharm Biodiscovery Latest Developments
Table 140. Basilea Pharmaceutica AG Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 142. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Basilea Pharmaceutica AG Main Business
Table 144. Basilea Pharmaceutica AG Latest Developments
Table 145. Biophage Pharma, Inc. Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Biophage Pharma, Inc. Anti-infectious Disease Drugs Product Portfolios and Specifications
Table 147. Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Biophage Pharma, Inc. Main Business
Table 149. Biophage Pharma, Inc. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Anti-infectious Disease Drugs
Figure 2. Anti-infectious Disease Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-infectious Disease Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Anti-infectious Disease Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Anti-infectious Disease Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Antibacterial Drugs
Figure 10. Product Picture of Antifungal Drugs
Figure 11. Product Picture of Antiviral Drugs
Figure 12. Product Picture of Antiparasitic Drugs
Figure 13. Global Anti-infectious Disease Drugs Sales Market Share by Type in 2022
Figure 14. Global Anti-infectious Disease Drugs Revenue Market Share by Type (2018-2023)
Figure 15. Anti-infectious Disease Drugs Consumed in Hospital
Figure 16. Global Anti-infectious Disease Drugs Market: Hospital (2018-2023) & (K Units)
Figure 17. Anti-infectious Disease Drugs Consumed in Institute of Medicine
Figure 18. Global Anti-infectious Disease Drugs Market: Institute of Medicine (2018-2023) & (K Units)
Figure 19. Anti-infectious Disease Drugs Consumed in Clinic
Figure 20. Global Anti-infectious Disease Drugs Market: Clinic (2018-2023) & (K Units)
Figure 21. Anti-infectious Disease Drugs Consumed in Others
Figure 22. Global Anti-infectious Disease Drugs Market: Others (2018-2023) & (K Units)
Figure 23. Global Anti-infectious Disease Drugs Sales Market Share by Application (2022)
Figure 24. Global Anti-infectious Disease Drugs Revenue Market Share by Application in 2022
Figure 25. Anti-infectious Disease Drugs Sales Market by Company in 2022 (K Units)
Figure 26. Global Anti-infectious Disease Drugs Sales Market Share by Company in 2022
Figure 27. Anti-infectious Disease Drugs Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Anti-infectious Disease Drugs Revenue Market Share by Company in 2022
Figure 29. Global Anti-infectious Disease Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Anti-infectious Disease Drugs Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Anti-infectious Disease Drugs Sales 2018-2023 (K Units)
Figure 32. Americas Anti-infectious Disease Drugs Revenue 2018-2023 ($ Millions)
Figure 33. APAC Anti-infectious Disease Drugs Sales 2018-2023 (K Units)
Figure 34. APAC Anti-infectious Disease Drugs Revenue 2018-2023 ($ Millions)
Figure 35. Europe Anti-infectious Disease Drugs Sales 2018-2023 (K Units)
Figure 36. Europe Anti-infectious Disease Drugs Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Anti-infectious Disease Drugs Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Anti-infectious Disease Drugs Revenue 2018-2023 ($ Millions)
Figure 39. Americas Anti-infectious Disease Drugs Sales Market Share by Country in 2022
Figure 40. Americas Anti-infectious Disease Drugs Revenue Market Share by Country in 2022
Figure 41. Americas Anti-infectious Disease Drugs Sales Market Share by Type (2018-2023)
Figure 42. Americas Anti-infectious Disease Drugs Sales Market Share by Application (2018-2023)
Figure 43. United States Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Anti-infectious Disease Drugs Sales Market Share by Region in 2022
Figure 48. APAC Anti-infectious Disease Drugs Revenue Market Share by Regions in 2022
Figure 49. APAC Anti-infectious Disease Drugs Sales Market Share by Type (2018-2023)
Figure 50. APAC Anti-infectious Disease Drugs Sales Market Share by Application (2018-2023)
Figure 51. China Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Anti-infectious Disease Drugs Sales Market Share by Country in 2022
Figure 59. Europe Anti-infectious Disease Drugs Revenue Market Share by Country in 2022
Figure 60. Europe Anti-infectious Disease Drugs Sales Market Share by Type (2018-2023)
Figure 61. Europe Anti-infectious Disease Drugs Sales Market Share by Application (2018-2023)
Figure 62. Germany Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Anti-infectious Disease Drugs Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Anti-infectious Disease Drugs Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Anti-infectious Disease Drugs Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Anti-infectious Disease Drugs Sales Market Share by Application (2018-2023)
Figure 71. Egypt Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Anti-infectious Disease Drugs in 2022
Figure 77. Manufacturing Process Analysis of Anti-infectious Disease Drugs
Figure 78. Industry Chain Structure of Anti-infectious Disease Drugs
Figure 79. Channels of Distribution
Figure 80. Global Anti-infectious Disease Drugs Sales Market Forecast by Region (2024-2029)
Figure 81. Global Anti-infectious Disease Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Anti-infectious Disease Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Anti-infectious Disease Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Anti-infectious Disease Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Anti-infectious Disease Drugs Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Anti-infectious Disease Drugs
Figure 2. Anti-infectious Disease Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-infectious Disease Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Anti-infectious Disease Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Anti-infectious Disease Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Antibacterial Drugs
Figure 10. Product Picture of Antifungal Drugs
Figure 11. Product Picture of Antiviral Drugs
Figure 12. Product Picture of Antiparasitic Drugs
Figure 13. Global Anti-infectious Disease Drugs Sales Market Share by Type in 2022
Figure 14. Global Anti-infectious Disease Drugs Revenue Market Share by Type (2018-2023)
Figure 15. Anti-infectious Disease Drugs Consumed in Hospital
Figure 16. Global Anti-infectious Disease Drugs Market: Hospital (2018-2023) & (K Units)
Figure 17. Anti-infectious Disease Drugs Consumed in Institute of Medicine
Figure 18. Global Anti-infectious Disease Drugs Market: Institute of Medicine (2018-2023) & (K Units)
Figure 19. Anti-infectious Disease Drugs Consumed in Clinic
Figure 20. Global Anti-infectious Disease Drugs Market: Clinic (2018-2023) & (K Units)
Figure 21. Anti-infectious Disease Drugs Consumed in Others
Figure 22. Global Anti-infectious Disease Drugs Market: Others (2018-2023) & (K Units)
Figure 23. Global Anti-infectious Disease Drugs Sales Market Share by Application (2022)
Figure 24. Global Anti-infectious Disease Drugs Revenue Market Share by Application in 2022
Figure 25. Anti-infectious Disease Drugs Sales Market by Company in 2022 (K Units)
Figure 26. Global Anti-infectious Disease Drugs Sales Market Share by Company in 2022
Figure 27. Anti-infectious Disease Drugs Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Anti-infectious Disease Drugs Revenue Market Share by Company in 2022
Figure 29. Global Anti-infectious Disease Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Anti-infectious Disease Drugs Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Anti-infectious Disease Drugs Sales 2018-2023 (K Units)
Figure 32. Americas Anti-infectious Disease Drugs Revenue 2018-2023 ($ Millions)
Figure 33. APAC Anti-infectious Disease Drugs Sales 2018-2023 (K Units)
Figure 34. APAC Anti-infectious Disease Drugs Revenue 2018-2023 ($ Millions)
Figure 35. Europe Anti-infectious Disease Drugs Sales 2018-2023 (K Units)
Figure 36. Europe Anti-infectious Disease Drugs Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Anti-infectious Disease Drugs Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Anti-infectious Disease Drugs Revenue 2018-2023 ($ Millions)
Figure 39. Americas Anti-infectious Disease Drugs Sales Market Share by Country in 2022
Figure 40. Americas Anti-infectious Disease Drugs Revenue Market Share by Country in 2022
Figure 41. Americas Anti-infectious Disease Drugs Sales Market Share by Type (2018-2023)
Figure 42. Americas Anti-infectious Disease Drugs Sales Market Share by Application (2018-2023)
Figure 43. United States Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Anti-infectious Disease Drugs Sales Market Share by Region in 2022
Figure 48. APAC Anti-infectious Disease Drugs Revenue Market Share by Regions in 2022
Figure 49. APAC Anti-infectious Disease Drugs Sales Market Share by Type (2018-2023)
Figure 50. APAC Anti-infectious Disease Drugs Sales Market Share by Application (2018-2023)
Figure 51. China Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Anti-infectious Disease Drugs Sales Market Share by Country in 2022
Figure 59. Europe Anti-infectious Disease Drugs Revenue Market Share by Country in 2022
Figure 60. Europe Anti-infectious Disease Drugs Sales Market Share by Type (2018-2023)
Figure 61. Europe Anti-infectious Disease Drugs Sales Market Share by Application (2018-2023)
Figure 62. Germany Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Anti-infectious Disease Drugs Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Anti-infectious Disease Drugs Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Anti-infectious Disease Drugs Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Anti-infectious Disease Drugs Sales Market Share by Application (2018-2023)
Figure 71. Egypt Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Anti-infectious Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Anti-infectious Disease Drugs in 2022
Figure 77. Manufacturing Process Analysis of Anti-infectious Disease Drugs
Figure 78. Industry Chain Structure of Anti-infectious Disease Drugs
Figure 79. Channels of Distribution
Figure 80. Global Anti-infectious Disease Drugs Sales Market Forecast by Region (2024-2029)
Figure 81. Global Anti-infectious Disease Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Anti-infectious Disease Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Anti-infectious Disease Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Anti-infectious Disease Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Anti-infectious Disease Drugs Revenue Market Share Forecast by Application (2024-2029)
